MESOMesoblast Limited
+1.2% today · −4.4% over a year
No score: too little data.
No dividend.
Mesoblast Limited (MESO) belongs to the Health care sector and is listed on Nasdaq; country: Australia. Over the past 12 months the price changed by −4.4%, with an annualised volatility of 57% and a largest fall of 43%. Hard red flags in our rules-based screen: Heavy dilution.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Share issuance (1 y)weighs on the score · better than 1% of peers
- Gross profit / assetsweighs on the score · better than 1% of peers
- Revenue growth (5 y, a year)weighs on the score · better than 1% of peers
Red flags and notes
- Serious warning. Share count growing more than 10 % a year over three years. More in the glossary → Share count growing more than 10 % a year over three years.
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Caution. At least one reverse split in the last three years. More in the glossary → At least one reverse split in the last three years.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Profitability and debt
- Return on equity
- −19.0%
- Gross margin
- 70.2%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- +1.2%
- 1 month
- +4.8%
- 1 year
- −4.4%
- Volatility, 1 yr
- 57.0%
- Max drawdown, 1 yr
- −43.0%
- Beta
- 1.26
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| CRSPCRISPR Therapeutics AG | 1/10 | 0.0% | −11.6% |
|---|---|---|---|
| STVNStevanato Group S.p.A. | 2/10 | 0.5% | −44.2% |
| TLXTelix Pharmaceuticals Limited | —/10 | 0.0% | −2.5% |
| IMTXImmatics N.V. | —/10 | 0.0% | −31.1% |
| VCREVicore Pharma Holding AB | —/10 | 0.0% | — |
| BHCBausch Health Companies Inc. | 1/10 | 0.0% | 22.3% |
| NAMSNewAmsterdam Pharma Company N.V. | 1/10 | 0.0% | −49.0% |
| PHVSPharvaris N.V. | 2/10 | 0.0% | 57.8% |
News and filings
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 3 Nov 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Oct 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 16 Oct 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 15 Oct 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 13 Oct 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 24 Sep 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Aug 2026
- MESOBLAST LTD: 20-F — Annual report of a foreign private issuer for the period ending 30 Jun 2026
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 27 Aug 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 24 Aug 2026
- MESOBLAST LTD: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 17 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.